uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
uniQure N.V. QURE now represents more than a single-program gene therapy story. Its profile is being reshaped by faster regulatory pathways, a narrower operating model and clinical work in rare neurological diseases. Those trends matter because investors are watching whether uniQure can build the next phase of growth beyond HEMGENIX-related economics and obligations. uniQure Is ...












